The US Market for Rx to OTC Switches, Forecasts to 2019, 7th Edition

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,995	200 Pages	Kalorama Information	February, 2015	KLI5459601

Best Price Guarantee
Price	from $1,995
Length	200 Pages
Publisher	Kalorama Information
Published Date	February, 2015
SKU	KLI5459601

The US Market for Rx to OTC Switches

Prescription products that are marketed as consumer products are known as Rx-to-OTC. They represent an important part of pharmaceutical strategy and a growing market. This report, The U.S. Market for Rx-to-OTC Switches focuses on several treatment segments in which Rx-to-OTC switches are available.

Patient-consumer awareness of health issues is driving the Rx-to-OTC market. Consumers are more prepared to take responsibility for their own health and are willing to purchase medicines over the counter. An increased focus on cost-savings, coupled with the effects of advertising and promotion, result a higher rate of OTC purchases. Elderly baby boomers, are taking greater interest in their health, and growing the Rx-to-OTC industry in America.

Segments profiled in the report include:

Smoking Cessation
Weight Loss
Gastrointestinal Drugs
Hair Loss Products
Hormones
Allergy
Analgesics, NSAIDs, and Pain Treatments
Anti-Infectives
Oral Care
Overactive Bladder
Rectal Ointments
Sleep-aids
Cough, Cold, and Sinus Products

In addition to the areas with switches in place, Kalorama Information has identified other areas which may be open to Rx-to-OTC switches in the future and are in development. These products are listed.

Present revenues and past revenues for segment markets consist of the switched brands and OTC drugs containing switched ingredients. Five year forecasts are provided.

In addition to this information, the study tracks current issues and trends affecting the industry and identifies trends that may arise in the future. Each segment provides an overview, descriptions of products on the market, market estimates and forecasts, and competitive analysis of leading providers.The report includes statistical information for conditions and diseases affecting the U.S. population, including detail discussions, tables and figures.

Executive Summary
- OVERVIEW
- SCOPE AND METHODOLOGY
- SIZE AND GROWTH OF THE MARKET
  - Table The U.S. Market for Rx-to-OTC Switches 2009-2019
- ISSUES AND TRENDS AFFECTING THE RX-TO-OTC SWITCHES MARKET
- LEADING PARTICIPANTS
The OTC Drug Industry
- OVERVIEW OF THE OVER-THE-COUNTER DRUG MARKET
  - Distribution Channels
    - Table Number of Retail Establishments in the United States and Non-Prescription Medicine Availability, 2012
  - Retail Market Value OTC Drug Industry
    - Table OTC Drug Retail Sales*, 2000-2014
- DEVELOPMENT OF THE RX-TO-OTC DRUG MARKET
  - Table Rx-to-OTC Switches Approved by the FDA 1976-2014
  - Table Statistics for Selected Rx-to-OTC Switches (United States)
  - Table Estimated OTC Sales by Product Type and Percent of Sales Attributed to Rx-to-OTC Switched Ingredients
- U.S. DRUG REGULATION
  - Expanding Drug Access with Behind the Counter Status
- NONPRESCRIPTION DRUG SAFE USE REGULATORY EXPANSION (NSURE)
  - Physician Uncertainty in Increasing Nonprescription Drug Access
  - Pharmacists Generally Favor Self-Medication
  - Online Resources for Health Information and Drug Selection
- U.S. DEMOGRAPHICS AND THE NON-PRESCRIPTION DRUG MARKET
  - Table The U.S. Population, 1980-2050
  - U.S. Population over 65
    - Table Percent U.S. Population Over Age 65 by Year, 2000-2050
  - U.S. Health Spending Indicators
    - Table U.S. Healthcare Industry Inflation Rates Healthcare Industry Consumer Price Index Comparisons 2000-2014 Data
- INTERNATIONAL TRENDS IN RX-TO-OTC SWITCHES
  - Table Legal Classification Status of Selected Ingredients Worldwide (updated through July 2014)
  - Table Individual Ingredients Switched from Rx to OTC by Country, 2013/2014
Allergy, Cough, Cold, and Sinus Products
- OVERVIEW
  - Antihistamines
  - Decongestants
  - Cough Preparations
  - Ophthalmic Preparations
  - Other Allergy Preparations
- DESCRIPTION OF CONDITIONS
  - Allergic Rhinitis
  - Common Cold
  - Sinusitis
  - Hives
  - Ocular Allergies
- PRODUCT ANALYSIS
  - Switched Products
    - Table Allergy, Cough, Cold, Sinus Product Ingredients Transferred from Rx-to-OTC Status
  - Recent Switch Activity
  - Prescription Products with Anticipated OTC Approvals
    - Table Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
- MARKET ANALYSIS
  - Market Size and Forecast
    - Table The U.S. Market for Rx-to-OTC Switches Allergy, Cough, Cold, and Sinus Product Revenues 2009-2019
  - Competitive Analysis
    - Table Leading Suppliers' Shares for U.S. Market for Rx-to-OTC Switches: Allergy, Cough, Cold, and Sinus Products, 2014
Analgesics and Other Pain Relievers
- OVERVIEW
  - Analgesics
  - Nonsteroidal Anti-inflammatory Drugs
  - Topical Pain Relievers and Other Similar Products
- DESCRIPTION OF CONDITIONS
  - Pain
  - Inflammation
- PRODUCT ANALYSIS
  - Switched Products
    - Table Analgesics, NSAIDs and Other Ingredients Transferred from Rxto-OTC Status
  - Prescription Products with Anticipated OTC Approvals
    - Table Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
- MARKET ANALYSIS
  - Market Size and Forecast
    - Table The U.S. Market for Rx-to-OTC Switches Analgesic Product Revenues 2009-2019
  - Competitive Analysis
    - Table Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC Switches Analgesics 2014
Anti-infectives
- OVERVIEW
  - Antibiotics
  - Antifungals
  - Antivirals
  - Antiparasitics
- DESCRIPTION OF CONDITIONS
  - Vaginal Infections
  - Athlete's Foot
  - Jock Itch
  - Ringworm
  - Dandruff
  - Scabies and Pediculosis
  - Pinworm
  - Fungal Nail Infections
- PRODUCT ANALYSIS
  - Switched Products
    - Table Anti-infectives Ingredients Transferred from Rx-to-OTC Status
  - Prescription Products with Anticipated OTC Approvals
    - Table Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
- MARKET ANALYSIS
  - Market Size and Forecast
    - Table The U.S. Market for Rx-to-OTC Switches Anti-infective Product Revenues 2009-2019
  - Competitive Analysis
    - Table Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC Switched Anti-infectives 2014
Gastrointestinal Drugs
- OVERVIEW
- DESCRIPTION OF CONDITIONS
  - Nausea
  - Diarrhea
  - Constipation
  - Heartburn
  - Acid reflux
- PRODUCT ANALYSIS
  - Switched Products
    - Table Gastrointestinal Drug Ingredients Transferred from Rx-to-OTC Status
  - Recent Switch Activity
  - Prescription Products with Anticipated OTC Approvals
    - Table Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
- MARKET AND COMPETITIVE ANALYSIS
  - Market Size and Forecast
    - Table The U.S. Market for Rx-to-OTC Switches Gastrointestinal Drug Revenues 2009-2019
  - Competitive Analysis
    - Table Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC Switches Gastrointestinal Drugs 2014
Smoking Cessation Products
- OVERVIEW
- DESCRIPTION OF CONDITIONS
  - Lung Cancer and Tobacco Use
- PRODUCT ANALYSIS
  - Switched Products
    - Table Smoking Cessation Product Ingredients Transferred from Rx-to-OTC Status
  - Prescription Products with Anticipated OTC Approvals
    - Table Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
- MARKET ANALYSIS
  - Market Size and Forecast
    - Table The U.S. Market for Rx-to-OTC Switches Smoking Cessation Product Revenues 2009-2019
  - Competitive Analysis
    - Table Leading Suppliers' Shares of the U.S. Market for Rx-to-OTC Switches Smoking Cessation Drugs 2014
Other Drug Classifications
- OVERVIEW
  - Contraceptives
  - Dental Rinses and Fluorides
  - Hair Growth Products
  - Rectal Ointments
  - Sleep Aids
  - Weight Management
- DESCRIPTION OF CONDITIONS
  - Pregnancy
    - Table U.S. Crude Birth Rate per 1,000 Persons 2000, 2005, 2010 and Projected 2015 and 2020
  - Dental carries
  - Hereditary Hair Loss
  - Hemorrhoids
  - Sleeplessness
  - Obesity
  - Urinary Incontinence/Overactive Bladder
- CONDITIONS WITH POSSIBLE FUTURE OTCTREATMENTS
  - Acne Vulgaris
  - Benign Prostate Hypertrophy (BPH)
  - Elevated Cholesterol
  - Erectile Dysfunction
  - Menopause and Hormone Replacement
  - Menorrhagia
  - Osteoporosis
- PRODUCT ANALYSIS
  - Switched Ingredients
    - Table Miscellaneous Drug Ingredients Transferred from Rx-to-OTC Status by Trade Name, Distributor, and Date of OTC Approval
  - Prescription Products with Anticipated OTC Approvals
    - Table Prescription Drugs with Anticipated OTC Approval by Ingredient, Trade Name, Distributor and Current Activity
- MARKET ANALYSIS
  - Current Market Segments
  - Short-Term New Product Segment Development; 2015-2016
  - New Product Segments; Post 2016
    - Table The U.S. Market for Rx-to-OTC Switches Other Drug Classification Product Revenues 2009-2019
  - Competitive Analysis
Total Rx-to-OTC Drug Market Summary
- OVERVIEW
- TOTAL MARKET SIZE AND FORECAST
  - Table The U.S. Market for Rx-to-OTC Switches 2009-2019
- SWITCH FORECAST IN THE UNITED STATES
  - Table Potential Rx-to-OTC Switches, 2015-2019
- MARKETS BY SEGMENTS
  - Table The U.S. Market for Rx-to-OTC Switches 2009-2019
- COMPETITIVE ANALYSIS
  - Table Leading Suppliers Significant Segments of Participation within the U.S. Market for Rx-to-OTC Switches, 2014
Profiles for Major Rx-to-OTC Participants
- INTRODUCTION
- STRATEGIES FOR CONTINUED PRODUCT GROWTH
  - Mergers and Acquisitions
- SIMULTANEOUS MARKETING - PRESCRIPTION VS OTC
- IMPACT ON THE PRESCRIPTION DRUG MANUFACTURER
- DIRECT-TO-CONSUMER ADVERTISING
- PATENT EXPIRATION
- BAYER
- BOEHRINGER INGELHEIM
- GLAXOSMITHKLINE
- JOHNSON &JOHNSON
- NOVARTIS
- PERRIGO COMPANY
- PFIZER
- PRESTIGE BRANDS
- PROCTER &GAMBLE
- RECKITT BENCKISER
- SANOFI/CHATTEM
- TEVA
Company Directory